文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

重症侵袭性A组链球菌感染患者的临床与分子流行病学特征:一项比利时多中心病例系列研究

Clinical and molecular epidemiological features of critically ill patients with invasive group A Streptococcus infections: a Belgian multicenter case-series.
PubMed 文献 · Ann Intensive Care · 2024-01-29
一句话结论2022–2023年比利时ICU重症GAS感染以M1UK谱系为主,sCAP常见且多伴病毒共感染,危重症医生应将化脓性链球菌纳入sCAP鉴别诊断。

该多中心回顾性研究纳入2022年1月至2023年5月比利时三家大学医院ICU收治的86例GAS感染患者(56例成人、30例儿童)。成人45%、儿童77%表现为重症社区获得性肺炎(sCAP),分别有45%和83%并发脓胸;化脓性链球菌肺炎患者中三分之二有病毒共感染,以流感为主(成人13例、儿童5例)。成人36%、儿童20%出现心源性休克,65%发生中毒性休克综合征;成人死亡率21%、儿童3%。55株菌基因组分析显示emm1占73%,其中83%为产毒M1UK谱系,取代了M1global谱系。作者结论认为重症GAS感染上升与M1UK谱系传入比利时相关,其他因素可能包括呼吸道病毒高强度流行和新冠 pandemic 后的免疫债;危重症医生应将化脓性链球菌纳入sCAP的鉴别诊断。

要点

  • 2022年1月至2023年5月比利时三家大学医院ICU共收治86例GAS感染(成人56例、儿童30例),成人死亡率21%、儿童3%。
  • 成人45%、儿童77%表现为sCAP,分别有45%和83%并发脓胸;化脓性链球菌肺炎患者中三分之二有病毒共感染,以流感为主(成人13例、儿童5例)。
  • 65%患者发生中毒性休克综合征;成人36%、儿童20%出现心源性休克。
  • 器官支持需求高:有创机械通气成人77%、儿童50%,肾脏替代治疗成人29%、儿童3%,体外膜氧合成人20%、儿童7%。
  • 55株菌基因组分析显示emm1占73%,其中83%为M1UK谱系,取代M1global谱系。

适用人群与场景

  • 2022年1月至2023年5月收治于比利时鲁汶、安特卫普和列日大学医院ICU的GAS感染患者,共86例(成人56例、儿童30例)。

红旗征与不能漏的情况

  • sCAP患者应警惕化脓性链球菌为致病病原体,尤其伴病毒共感染(以流感为主)时。
  • GAS感染可并发脓胸(成人45%、儿童83%的肺炎病例)、中毒性休克综合征(65%)和心源性休克(成人36%、儿童20%)。

研究设计与关键结果

  • 多中心回顾性病例系列:2022年1月至2023年5月比利时三家大学医院ICU共86例GAS感染患者(成人56例、儿童30例)。
  • sCAP占成人45%、儿童77%,并发脓胸分别为45%和83%;化脓性链球菌肺炎患者中三分之二有病毒共感染,以流感为主(成人13例、儿童5例)。
  • 其他表现:坏死性筋膜炎占成人23%,其他严重皮肤/软组织感染占成人16%、儿童13%,耳鼻喉感染占成人13%、儿童13%。
  • 心源性休克占成人36%、儿童20%;中毒性休克综合征56例(65%)。
  • 器官支持:有创机械通气成人77%、儿童50%,肾脏替代治疗成人29%、儿童3%,体外膜氧合成人20%、儿童7%。
  • 死亡率成人21%、儿童3%。
  • 55/86例菌株基因组分析:emm1占73%,其中83%为产毒M1UK谱系,取代M1global谱系。

证据类型、等级与局限

  • 多中心回顾性病例系列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,危重症医生应将化脓性链球菌纳入sCAP的鉴别诊断。
  • 作者认为,2022–23年重症GAS感染上升与M1UK谱系传入比利时相关,其他因素可能包括呼吸道病毒高强度流行和新冠 pandemic 后的免疫债。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Recent alerts have highlighted an increase in group A streptococcal (GAS) infections since 2022 in Europe and the United States. Streptococcus pyogenes can cause limited skin or mucosal disease, but can also present as severe invasive disease necessitating critical care. We performed a multicenter retrospective study of patients with GAS infections recently admitted to Belgian intensive care units (ICUs) since January 2022. We describe patient characteristics and investigate the molecular epidemiology of the S. pyogenes strains involved.

RESULTS: Between January 2022 and May 2023, a total of 86 cases (56 adults, 30 children) with GAS disease were admitted to critical care in the university hospitals of Leuven, Antwerp and Liège. We noted a strikingly high incidence of severe community-acquired pneumonia (sCAP) (45% of adults, 77% of children) complicated with empyema in 45% and 83% of adult and pediatric cases, respectively. Two-thirds of patients with S. pyogenes pneumonia had viral co-infection, with influenza (13 adults, 5 children) predominating. Other disease presentations included necrotizing fasciitis (23% of adults), other severe skin/soft tissue infections (16% of adults, 13% of children) and ear/nose/throat infections (13% of adults, 13% of children). Cardiogenic shock was frequent (36% of adults, 20% of children). Fifty-six patients (65%) had toxic shock syndrome. Organ support requirements were high and included invasive mechanical ventilation (77% of adults, 50% of children), renal replacement therapy (29% of adults, 3% of children) and extracorporeal membrane oxygenation (20% of adults, 7% of children). Mortality was 21% in adults and 3% in children. Genomic analysis of S. pyogenes strains from 55 out of 86 patients showed a predominance of emm1 strains (73%), with a replacement of the M1global lineage by the toxigenic M1UK lineage (83% of emm1 strains were M1UK).

CONCLUSIONS: The recent rise of severe GAS infections (2022-23) is associated with introduction of the M1UK lineage in Belgium, but other factors may be at play-including intense circulation of respiratory viruses and potentially an immune debt after the COVID pandemic. Importantly, critical care physicians should include S. pyogenes as causative pathogen in the differential diagnosis of sCAP.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Peetermans M, Matheeussen V, Moerman C, et al. Clinical and molecular epidemiological features of critically ill patients with invasive group A Streptococcus infections: a Belgian multicenter case-series. Ann Intensive Care. 2024. PMID: 38286885. doi:10.1186/s13613-024-01249-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。